Diapin Therapeutics
Plug and Play · Novel Therapies for Cardiovascular and Metabolic Diseases
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 Luminist LabsShared: liver disease, non alcoholic, steatohepatitisAcquiredOther | Other | Acquired | YCW16 |
 Adipo TherapeuticsShared: metabolic disease, innovative treatment, novelNot statedOther | Other | Not stated | Plug and Play |
 Gerostate AlphaShared: developing novel, disease, therapeuticInactiveOther | Other | Inactive | YCS18 |
 Attest LaboratoriesShared: metabolic condition, key, developingNot statedOther | Other | Not stated | Plug and Play |
 Ochre BioShared: liver disease, developingActiveOther | Other | Active | YC +1W20 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 CellChorusShared: novel therapy, therapeutic, includeActiveAI | AI | Active | YCS21 |
 ChroniCareShared: disease patientNot statedOther | Other | Not stated | Antler2025 |
 RNAReviveShared: liver disease, therapy, antiNot statedOther | Other | Not stated | Plug and Play |
 Altay TherapeuticsShared: liver disease, therapy, targetingActiveAI | AI | Active | YCW20 |
 Grannus TherapeuticsShared: developing novel, lifetech, antiNot statedOther | Other | Not stated | Plug and Play |
Also from Plug and Play
All of Plug and Play
Programs
| Program | Cohort | Source |
|---|---|---|
 Plug and Play | Not stated | Plug and Play Page |
About Diapin Therapeutics
Diapin Therapeutics is a health and lifetech company focused on developing novel therapies for cardiovascular and metabolic diseases. The company’s mission centers on advancing innovative treatments to address critical unmet medical needs in these areas. Its key products include DT678, a best-in-class anti-platelet therapy designed to prevent stroke and heart attacks in cardiovascular disease patients, and DT109, a peptide targeting metabolic conditions such as non-alcoholic fatty liver disease (NAFLD), metabolic-associated steatohepatitis (MASH), and atherosclerosis. Both assets originated from academic research and are progressing through clinical and preclinical development stages. Diapin Therapeutics contributes to medical innovation by translating cutting-edge scientific discoveries into promising therapeutic candidates aimed at improving patient outcomes in complex chronic diseases.
- Category
- Other
- Location
- United States
- Checked
- 2h ago
Diapin Therapeutics: questions
Which accelerators did Diapin Therapeutics go through?
Diapin Therapeutics is listed by Plug and Play.
Where is Diapin Therapeutics based?
Diapin Therapeutics lists United States as its location on Plug and Play's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.